Human Coagulation Factor XI quantitates human Coagulation Factor XI in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Coagulation Factor XI.
Human Coagulation Factor XI quantitates human Coagulation Factor XI in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Coagulation Factor XI.
Human Coagulation Factor XI quantitates human Coagulation Factor XI in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Coagulation Factor XI.
This gene codes the coagulation factor XI of the blood clotting cascade. This protein is present in plasma as a zymogen, which is a unique plasma coagulation enzyme because it exists as a homodomer composed of two identical polypeptide chains connected by disulfide bridges. When plasma factor XI is activated, an internal peptide bond is cleaved by factor XIIa (or XII) in each of the two chains, resulting in the activation of factor XIa, a serine protease consisting of two heavy chains and two light chains held together by disulfide bridges. This activated plasma factor XI triggers the intermediate phase of the intrismic pathway of blood clotting by activating factor IX. The defects of this factor cause Rosenthal syndrome, a blood clotting disorder.
Sensitivity
Sensitivity of dosage: 10 pg/mL.
Measurement range
Dose range: 10 to 2,500 pg/mL.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Factor XI.
Samples
Type of sample: Plasma, Serum, Surnatant (plasma volume, 50 µl; Serum, 50 µl; Supernatant, 50 µl).